Authors: Hasebe, T Hua, J Someya, A Morain, P Checler, F Nagaoka, I

Citation: T. Hasebe et al., Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells, J LEUK BIOL, 69(6), 2001, pp. 963-968

Authors: Marighetto, A Touzani, K Etchamendy, N Torrea, CC De Nanteuil, G Guez, D Jaffard, R Morain, P

Citation: A. Marighetto et al., Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: Effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor, LEARN MEM, 7(3), 2000, pp. 159-169

Authors: Morain, P Robin, JL De Nanteuil, G Jochemsen, R Heidet, V Guez, D

Citation: P. Morain et al., Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study, BR J CL PH, 50(4), 2000, pp. 350-359

Authors: Petit, A Barelli, H Morain, P Checler, F

Citation: A. Petit et al., Novel proline endopeptidase inhibitors do not modify A beta 40/42 formation and degradation by human cells expressing wild-type and Swedish mutated beta-amyloid precursor protein, BR J PHARM, 130(7), 2000, pp. 1613-1617

Authors: Barelli, H Petit, A Hirsch, E Wilk, S De Nanteuil, G Morain, P Checler, F

Citation: H. Barelli et al., S17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase, BIOC BIOP R, 257(3), 1999, pp. 657-661